1. Home
  2. NOTV vs DTIL Comparison

NOTV vs DTIL Comparison

Compare NOTV & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.84

Market Cap

29.9M

Sector

Health Care

ML Signal

HOLD

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$5.03

Market Cap

123.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTV
DTIL
Founded
1974
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9M
123.0M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
NOTV
DTIL
Price
$0.84
$5.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$3.00
$47.00
AVG Volume (30 Days)
1.6M
197.8K
Earning Date
12-03-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$513,024,000.00
$698,000.00
Revenue This Year
$6.26
N/A
Revenue Next Year
$45.49
$34.30
P/E Ratio
N/A
N/A
Revenue Growth
4.54
N/A
52 Week Low
$0.66
$3.61
52 Week High
$6.48
$8.82

Technical Indicators

Market Signals
Indicator
NOTV
DTIL
Relative Strength Index (RSI) 38.94 41.75
Support Level $0.79 $4.61
Resistance Level $0.86 $5.09
Average True Range (ATR) 0.07 0.33
MACD 0.01 0.03
Stochastic Oscillator 33.21 37.30

Price Performance

Historical Comparison
NOTV
DTIL

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Share on Social Networks: